Announcements Trials
Browse Landscape

Status

Completed 31Terminated 4Unknown 1Recruiting 1Not yet recruiting 1No longer available 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 18Lymphoid 3Other hematologic neoplasm 2Myeloid 1

Conditions

Myelodysplastic Syndromes 188Leukemia, Myeloid, Acute 159Myeloproliferative Disorders 83Leukemia, Myelogenous, Chronic, BCR-ABL Positive 72Precursor Cell Lymphoblastic Leukemia-Lymphoma 61Primary Myelofibrosis 54Leukemia, Myelomonocytic, Chronic 45Leukemia 35Polycythemia Vera 33Multiple Myeloma 30Hematologic Neoplasms 30Thrombocythemia, Essential 29Lymphoma, Non-Hodgkin 28Leukemia, Biphenotypic, Acute 25Hodgkin Disease 25Lymphoma 23Myelodysplastic-Myeloproliferative Diseases 18Leukemia, Lymphocytic, Chronic, B-Cell 18Leukemia, Myeloid, Chronic-Phase 14Blastic Plasmacytoid Dendritic Cell Neoplasm 14Neoplasms 13Burkitt Lymphoma 12Mastocytosis 11Leukemia, Myeloid 11Graft vs Host Disease 11Blast Crisis 11Anemia, Refractory, with Excess of Blasts 11Lymphoma, Follicular 10Anemia, Aplastic 10Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Monoclonal Gammopathy of Undetermined Significance × Myeloid × Clear all
NCT02269592 2026-05-07

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Dana-Farber Cancer Institute

Recruiting
10,000 enrolled
LymphoidMyeloidOther hematologic neoplasmPlasma cell

Smoldering Multiple Myeloma, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡